Constanta Timcheva
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Global Cancer Incidence and Screening
- Inflammatory Biomarkers in Disease Prognosis
- PARP inhibition in cancer therapy
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 5
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 4
- Inflammatory Biomarkers in Disease Prognosis 3
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Tudor–Eliade Ciuleanu (1 shared paper)G. Bodoky (1 shared paper)G. Pover (1 shared paper)Niall C. Tebbutt (1 shared paper)David R. Spigel (1 shared paper)Phillip J. Stella (1 shared paper)Piotr Zaborek (2 shared papers)Ljiljana Stamatović (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Gynecologic Oncology (2 papers)Annals of Oncology (2 papers)British Journal of Cancer (2 papers)ESMO Open (1 paper)
- Partner nations
- United KingdomBulgariaHungary
In The Last Decade
Constanta Timcheva
23 papers receiving 471 citations
Peers
Comparison fields: 5 of 57
- Oncology 326
- Cancer Research 97
- Pulmonary and Respiratory Medicine 67
- Pathology and Forensic Medicine 28
- Molecular Biology 115
Countries citing papers authored by Constanta Timcheva
This map shows the geographic impact of Constanta Timcheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constanta Timcheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constanta Timcheva more than expected).
Fields of papers citing papers by Constanta Timcheva
This network shows the impact of papers produced by Constanta Timcheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constanta Timcheva. The network helps show where Constanta Timcheva may publish in the future.
Co-authors
The 25 scholars most cited alongside Constanta Timcheva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 198 | |
| 2 | 2013 | 108 | |
| 3 | 2020 | 48 | |
| 4 | 2020 | 29 | |
| 5 | 2009 | 14 | |
| 6 | 1996 | 13 | |
| 7 | 2023 | 13 | |
| 8 | 2010 | 12 | |
| 9 | 2016 | 9 | |
| 10 | 2021 | 7 | |
| 11 | 2017 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 4 | |
| 14 | 2008 | 3 | |
| 15 | 2012 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 2 | |
| 19 | 2019 | 2 | |
| 20 | 2023 | 1 |
About Constanta Timcheva
Constanta Timcheva is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Genetics, having authored 23 papers that have together received 481 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), PARP inhibition in cancer therapy (5 papers), Lung Cancer Research Studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), BRCA gene mutations in cancer (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Oncology (326 citations), Cancer Research (97 citations), Pulmonary and Respiratory Medicine (67 citations), Pathology and Forensic Medicine (28 citations) and Molecular Biology (115 citations). Constanta Timcheva has collaborated with scholars based in United Kingdom, Bulgaria and Hungary. Frequent co-authors include Tudor–Eliade Ciuleanu, G. Bodoky, G. Pover, Niall C. Tebbutt, David R. Spigel, Phillip J. Stella, Piotr Zaborek, Ljiljana Stamatović, Damir Vrbanec and J. Eglītis. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, British Journal of Cancer and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.